Nuntaya PunyadeeDumrong MairiangSomchai ThiemmecaChulaluk KomoltriWirichada Pan-ngumNusara ChomaneeKomgrid CharngkaewNattaya TangthawornchaikulWannee LimpitikulSirijitt VasanawathanaPrida MalasitPanisadee AvirutnanMahidol UniversityThailand National Center for Genetic Engineering and BiotechnologySongkhla HospitalKhon Kaen Regional Hospital2018-11-232018-11-232015-01-01Journal of Virology. Vol.89, No.3 (2015), 1587-1607109855140022538X2-s2.0-84921466925https://repository.li.mahidol.ac.th/handle/20.500.14594/35284© 2015, American Society for Microbiology. Shedding of microparticles (MPs) is a consequence of apoptotic cell death and cellular activation. Low levels of circulating MPs in blood help maintain homeostasis, whereas increased MP generation is linked to many pathological conditions. Herein, we investigated the role of MPs in dengue virus (DENV) infection. Infection of various susceptible cells by DENV led to apoptotic death and MP release. These MPs harbored a viral envelope protein and a nonstructural protein 1 (NS1) on their surfaces. Ex vivo analysis of clinical specimens from patients with infections of different degrees of severity at multiple time points revealed that MPs generated from erythrocytes and platelets are two major MP populations in the circulation of DENV-infected patients. Elevated levels of red blood cell-derived MPs (RMPs) directly correlated with DENV disease severity, whereas a significant decrease in platelet-derived MPs was associated with a bleeding tendency. Removal by mononuclear cells of complement-opsonized NS1-anti-NS1 immune complexes bound to erythrocytes via complement receptor type 1 triggered MP shedding in vitro, a process that could explain the increased levels of RMPs in severe dengue. These findings point to the multiple roles of MPs in dengue pathogenesis. They offer a potential novel biomarker candidate capable of differentiating dengue fever from the more serious dengue hemorrhagic fever.Mahidol UniversityAgricultural and Biological SciencesImmunology and MicrobiologyMicroparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infectionArticleSCOPUS10.1128/JVI.02207-14